William Kielbasa

955 total citations
35 papers, 704 citations indexed

About

William Kielbasa is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, William Kielbasa has authored 35 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Psychiatry and Mental health, 12 papers in Cellular and Molecular Neuroscience and 11 papers in Molecular Biology. Recurrent topics in William Kielbasa's work include Migraine and Headache Studies (9 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Attention Deficit Hyperactivity Disorder (5 papers). William Kielbasa is often cited by papers focused on Migraine and Headache Studies (9 papers), Neurotransmitter Receptor Influence on Behavior (7 papers) and Attention Deficit Hyperactivity Disorder (5 papers). William Kielbasa collaborates with scholars based in United States, United Kingdom and Singapore. William Kielbasa's co-authors include Robert E. Stratford, Ho‐Leung Fung, J. Tauscher, Xiaomei Peng, Donald R. Gehlert, Tonya Quinlan, J Brandt, Stephen P. Hunt, François Vandenhende and Daniel W. Hommer and has published in prestigious journals such as Science, NeuroImage and Neurology.

In The Last Decade

William Kielbasa

34 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Kielbasa United States	14	266	255	178	115	107	35	704
Rolf Larisch Germany	23	326 1.2×	153 0.6×	192 1.1×	82 0.7×	56 0.5×	63	1.4k
Christian Lange‐Asschenfeldt Germany	14	210 0.8×	204 0.8×	147 0.8×	155 1.3×	103 1.0×	57	773
Michael J. Seminerio United States	18	215 0.8×	277 1.1×	299 1.7×	112 1.0×	184 1.7×	44	777
Catherine M. Davis United States	20	260 1.0×	107 0.4×	258 1.4×	114 1.0×	76 0.7×	46	1.0k
Rena Li United States	13	164 0.6×	130 0.5×	256 1.4×	233 2.0×	78 0.7×	20	1.0k
Liang‐Hao Guo Germany	18	205 0.8×	210 0.8×	203 1.1×	363 3.2×	67 0.6×	25	851
Tokutaro Komiyama Japan	19	544 2.0×	146 0.6×	312 1.8×	79 0.7×	49 0.5×	33	901
Alfredo Oliveros United States	19	353 1.3×	133 0.5×	364 2.0×	116 1.0×	26 0.2×	51	932
Michal Taler Israel	16	214 0.8×	97 0.4×	203 1.1×	85 0.7×	36 0.3×	37	835
Rezzan Aker Türkiye	19	569 2.1×	374 1.5×	190 1.1×	68 0.6×	46 0.4×	59	1.1k

Countries citing papers authored by William Kielbasa

Since Specialization

Citations

This map shows the geographic impact of William Kielbasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Kielbasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Kielbasa more than expected).

Fields of papers citing papers by William Kielbasa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Kielbasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Kielbasa. The network helps show where William Kielbasa may publish in the future.

Co-authorship network of co-authors of William Kielbasa

This figure shows the co-authorship network connecting the top 25 collaborators of William Kielbasa. A scholar is included among the top collaborators of William Kielbasa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Kielbasa. William Kielbasa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Svensson, Kjell, Claire Brittain, Brian J. Eastwood, et al.. (2021). The Dopamine D1 Receptor Positive Allosteric Modulator Mevidalen (LY3154207) Enhances Wakefulness in the Humanized D1 Mouse and in Sleep-Deprived Healthy Male Volunteers. Journal of Pharmacology and Experimental Therapeutics. 380(3). 143–152. 7 indexed citations

Stauffer, Virginia L., Ira Turner, William Kielbasa, et al.. (2020). Effect of age on pharmacokinetics, efficacy, and safety of galcanezumab treatment in adult patients with migraine: results from six phase 2 and phase 3 randomized clinical trials. The Journal of Headache and Pain. 21(1). 79–79. 12 indexed citations

Martinez, James M., Nada Hindiyeh, Greg Anglin, et al.. (2020). Assessment of immunogenicity from galcanezumab phase 3 trials in patients with episodic or chronic migraine. Cephalalgia. 40(9). 978–989. 9 indexed citations

Kielbasa, William, Krista M Phipps, Fanni Natanegara, et al.. (2020). A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme. Alzheimer s & Dementia. 16(S9). 9 indexed citations

Biglan, Kevin, Paul Ardayfio, William Kielbasa, & Kjell Svensson. (2019). A D1 receptor positive allosteric modulator (LY3154207) enhances wakefulness in sleep deprived healthy volunteers (P3.6-041). Neurology. 92(15_supplement). 1 indexed citations

Stauffer, Virginia L., Michel Lantéri‐Minet, William Kielbasa, et al.. (2018). Comparison between prefilled syringe and autoinjector devices on patient-reported experiences and pharmacokinetics in galcanezumab studies. Patient Preference and Adherence. Volume 12. 1785–1795. 32 indexed citations

Nakano, Masako, et al.. (2017). Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Galcanezumab, a Monoclonal Antibody to Calcitonin Gene-Related Peptide, in Healthy Japanese and Caucasian Subjects . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 48(4). 131–139. 4 indexed citations

Lin, Daniel, Christopher J. Kratochvil, Wen Xu, et al.. (2014). A Randomized Trial of Edivoxetine in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 24(4). 190–200. 18 indexed citations

Jin, Ling, Wen Xu, Daniel Gruener, et al.. (2013). Clinical Outcomes from an Open-Label Study of Edivoxetine Use in Pediatric Patients with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 23(3). 200–207. 9 indexed citations

10.

Kielbasa, William, et al.. (2013). The effect of hepatic or renal impairment on the pharmacokinetics of edivoxetine, a selective norepinephrine transporter reuptake inhibitor. European Journal of Clinical Pharmacology. 69(12). 2011–2019. 4 indexed citations

11.

Kielbasa, William, Tonya Quinlan, Ling Jin, et al.. (2012). Pharmacokinetics and Pharmacodynamics of Edivoxetine (LY2216684), a Norepinephrine Reuptake Inhibitor, in Pediatric Patients with Attention-Deficit/ Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 22(4). 269–276. 13 indexed citations

12.

Dubé, Sanjay, et al.. (2009). A study of the effects of LY2216684, a selective norepinephrine reuptake inhibitor, in the treatment of major depression. Journal of Psychiatric Research. 44(6). 356–363. 23 indexed citations

13.

Kielbasa, William, Smriti Iyengar, François Vandenhende, et al.. (2009). Development of the 2nd generation neurokinin-1 receptor antagonist LY686017 for social anxiety disorder. European Neuropsychopharmacology. 20(2). 80–87. 43 indexed citations

14.

George, David T., Jodi M. Gilman, Jacqueline Hersh, et al.. (2008). Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism. Science. 319(5869). 1536–1539. 168 indexed citations

15.

Kielbasa, William, J. Cory Kalvass, & Robert E. Stratford. (2008). Microdialysis Evaluation of Atomoxetine Brain Penetration and Central Nervous System Pharmacokinetics in Rats. Drug Metabolism and Disposition. 37(1). 137–142. 33 indexed citations

16.

Seneca, Nicholas, Balázs Gulyás, Andrea Varrone, et al.. (2006). Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: a PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2. Psychopharmacology. 188(1). 119–127. 63 indexed citations

17.

Kielbasa, William, et al.. (2001). Systemic Biochemical Effects of Inhaled NO in Rats: Increased Expressions of NOS III, Nitrotyrosine-, and Phosphotyrosine-Immunoreactive Proteins in Liver and Kidney Tissues. Nitric Oxide. 5(6). 587–594. 6 indexed citations

18.

Kielbasa, William & Ho‐Leung Fung. (2000). Nitrite Inhalation in Rats Elevates Tissue NOS III Expression and Alters Tyrosine Nitration and Phosphorylation. Biochemical and Biophysical Research Communications. 275(2). 335–342. 17 indexed citations

19.

Kielbasa, William & Ho‐Leung Fung. (2000). Relationship between steady-state pharmacokinetics and hemodynamic effects of inhaled isobutyl nitrite in conscious rats. PubMed. 2(2). 8–15. 6 indexed citations

20.

Kielbasa, William, John Anthony Bauer, & Ho‐Leung Fung. (1999). Analysis of isobutyl nitrite inhalant in rat and human blood: application for pharmacokinetic investigations. Journal of Chromatography B Biomedical Sciences and Applications. 734(1). 83–89. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact